BAX and breast cancer: A study by Liu et al. (2019) showed that baicalein damaged MMP, downregulated antiapoptotic protein Bcl-2 expression, upregulated proapoptotic protein Bax expression, and promoted the release of CytoC and activated caspase-9/3 in BC cells by increasing intracellular ROS levels.